Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
17.30
Nov 06 • 3:59 PM ET Dollar change+1.40 Percentage change(8.81%)
Aftermarket Close
17.30
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Nov 05, 11:02 PMArdent raises 2026 EBITDA guidance as labor costs fall and volumes improve
Index
RUT
Market Cap
2.44B
Enterprise Value
4.32B
Income
146.22M
Sales
6.45B
Book/sh
9.91
Cash/sh
5.44
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
25200
IPO
Jul 18, 2024
P/E
16.80
Forward P/E
14.11
PEG
1.33
P/S
0.38
P/B
1.75
P/C
3.18
P/FCF
8.64
EV/EBITDA
8.59
EV/Sales
0.67
Quick Ratio
2.03
Current Ratio
2.13
Debt/Eq
1.62
LT Debt/Eq
1.60
Option/Short
Yes / Yes
EPS (ttm)
1.03
EPS next Y
1.23
EPS next Q
0.34
EPS this Y
6.21%
EPS next Y
20.24%
EPS next 5Y
10.65%
EPS past 3/5Y
-10.04% -
Sales past 3/5Y
7.23% 8.73%
EPS Y/Y TTM
-28.50%
Sales Y/Y TTM
2.03%
EPS Q/Q
289.05%
Sales Q/Q
3.05%
Insider Own
84.41%
Insider Trans
0.02%
Inst Own
15.84%
Inst Trans
1.12%
ROA
2.78%
ROE
11.10%
ROIC
4.03%
Gross Margin
15.40%
Oper. Margin
5.22%
Profit Margin
2.27%
SMA20
38.56%
SMA50
51.21%
SMA200
71.01%
Trades
Shs Outstand
140.93M
Shs Float
21.99M
52W High
16.23 6.59%
52W Low
7.71 124.38%
Volatility
9.19% 5.03%
ATR (14)
0.80
RSI (14)
85.26
Beta
0.15
Rel Volume
7.51
Avg Volume
461.79K
Volume
3,465,887
Perf Week
43.81%
Perf Month
56.28%
Perf Quarter
56.42%
Perf Half Y
71.12%
Perf YTD
95.92%
Perf Year
19.64%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
15.90
Price
17.30
Change %
8.81%
Consensus
Buy
Avg. Price Target
$15.21
Implied Upside
-12.1%
Analysts14incl. previous ratings
Rating Distribution8 Buy · 5 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 23, 2026Initiated
BMO logoBBMO Capital Markets
Market Perform$11-36.4%
Nov 17, 2025Downgrade
KEY logoKKeyBanc Capital Markets
Overweight → Sector Weight
Nov 14, 2025Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight
Oct 14, 2025Initiated
GS logoGGoldman
Neutral$19+9.8%
Sep 10, 2025Initiated
UBS logoUUBS
Buy$17-1.7%
Jul 16, 2025Downgrade
BAC logoBBofA Securities
Neutral → Underperform$14.60-15.6%
Dec 17, 2024Resumed
JPM logoJJP Morgan
Neutral$20+15.6%
Nov 06, 2024Downgrade
BAC logoBBofA Securities
Buy → Neutral$22 → $19+9.8%
Oct 11, 2024Initiated
KEY logoKKeyBanc Capital Markets
Overweight$24+38.7%
Aug 12, 2024Initiated
TFC logoTTruist
Buy$21+21.4%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bonick MartinFormer Officer & DirectorAug 27 '26Proposed Sale11.0835,930398,031Aug 27 04:18 PM
Bonick MartinFormer Officer & DirectorAug 25 '26Proposed Sale11.1735,930401,355Aug 25 04:47 PM
Bonick MartinFormer Officer & DirectorAug 20 '26Proposed Sale10.5035,930377,364Aug 20 04:23 PM
Bonick MartinFormer Officer & DirectorAug 18 '26Proposed Sale10.9535,930393,482Aug 18 04:11 PM
DeMichiei RobertDirectorJun 05 '26Buy8.7311,26098,30035,564Jun 08 12:50 PM
LUMSDAINE ALFREDChief Financial OfficerJun 05 '26Buy8.8110,00088,100329,183Jun 08 12:50 PM
Ardent Health, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals through its subsidiaries. The company was founded in 1993 and is headquartered in Brentwood, TN.
PresidentMr. David Caspers
Chief Financial OfficerMr. Alfred Lumsdaine C.P.A.
Senior VP & Chief Accounting OfficerMr. David Byers C.P.A.
Chief Technology OfficerMr. Lonnie Garrison PMP
Chief Administrative OfficerMs. Caitlin Franklin